Replies to post #109 on Nanomix Corp. (NNMX)

[QuickDraw007]

Boston Therapeutics' Hong Kong Affiliate Advance Pharmaceutical's BTI-320 Clinical Trial Reaches Mid-Point by Enrolling 30 Patients at the Chinese University of Hong Kong
http://www.otcmarkets.com/stock/BTHE/news/Boston-Therapeutics--Hong-Kong-Affiliate-Advance-Pharmaceutical-s-BTI-320-Clinical-Trial-Reaches-Mid-Point-by-Enrolling-30-Patients-at-the-Chinese-University-of-Hong-Kong?id=109136&b=y